Serum cystatin C and the risk of Alzheimer disease in elderly men
about
Multiplexed immunoassay panel identifies novel CSF biomarkers for Alzheimer's disease diagnosis and prognosisDementia risk in renal dysfunction: A systematic review and meta-analysis of prospective studies.Update on the core and developing cerebrospinal fluid biomarkers for Alzheimer disease.Cystatin C is released in association with exosomes: a new tool of neuronal communication which is unbalanced in Alzheimer's disease.Predicting dementia: role of dementia risk indices.Kidney function and cognitive health in older adults: the Cardiovascular Health Study.Differential effects of indoxyl sulfate and inorganic phosphate in a murine cerebral endothelial cell line (bEnd.3).Association of cystatin C with adverse outcomes.Proteases and proteolysis in Alzheimer disease: a multifactorial view on the disease process.Higher levels of cystatin C are associated with worse cognitive function in older adults with chronic kidney disease: the chronic renal insufficiency cohort cognitive study.Alterations of CSF cystatin C levels and their correlations with CSF Αβ40 and Αβ42 levels in patients with Alzheimer's disease, dementia with lewy bodies and the atrophic form of general paresisCystatin C and cognitive impairment 10 years later in older women.Cystatin C in Alzheimer's disease.Identifying biomarkers of dementia prevalent among amnestic mild cognitively impaired ethnic female patients.Extracellular vesicle protein levels are related to brain atrophy and cerebral white matter lesions in patients with manifest vascular disease: the SMART-MR study.Plasma Cystatin C and High-Density Lipoprotein Are Important Biomarkers of Alzheimer's Disease and Vascular Dementia: A Cross-Sectional Study.Patterns of compensation and vulnerability in normal subjects at risk of Alzheimer's disease.Cysteine cathepsins in neurological disorders.Direct analytical sample quality assessment for biomarker investigation: qualifying cerebrospinal fluid samples.Physical activity predicts reduced plasma β amyloid in the Cardiovascular Health Study.Cystatin C in aging and in Alzheimer's disease.Cystatin C protects neuronal cells from amyloid-beta-induced toxicity.Extracellular Vesicles in Brain Tumors and Neurodegenerative Diseases.Loss of Neuroprotective Factors in Neurodegenerative Dementias: The End or the Starting Point?The CST3 B haplotype is associated with frontotemporal lobar degeneration.
P2860
Q28740917-AAD49A07-9E34-4B69-8800-717EE3990D63Q30240101-380966C2-5D47-4EDA-9338-F5A938709D20Q30845482-35D3F5F1-1FC6-4378-97DE-556792D29E20Q33505900-822C56E7-374D-4557-A080-B5AFDECD8BE0Q33588556-C8A77601-F63D-4DB9-9A55-1FA6D460AD09Q33806588-EC533BA5-30C1-47BB-8159-7596C95585FAQ33813622-CB3582D8-0DA5-4519-A62C-F0DD38428C09Q33932292-EAFBE3A7-7530-4DD3-8A81-96E53B699FCCQ34110227-BA28C809-0CCF-499A-83A5-E1954216C77FQ34361219-99390BD5-D04E-4343-B750-9E358C299B4FQ34576418-B77B93EE-EDC9-493C-93CF-B16E59ABE63AQ35661812-45B9B06B-3EE4-4931-A90B-7F2AFF1F9290Q36078684-096BCF2A-07EF-4544-9C53-83C736A6CCD1Q37346081-4C2EAFEC-D573-41EC-BD9F-DA661CE68146Q37517034-B8AF99E2-5273-4CA4-883D-3432B0A60DC0Q37628115-07565E68-DCAE-49D1-B2B0-DC7F58154221Q37632619-3DA3F08E-0650-4886-BB22-E734E605805DQ38162775-A7923B0F-149F-4AE2-8576-55FFB3AEF3EAQ38232016-C59FA377-AD08-452B-972D-D7D2E25160A6Q38793329-43E6BDD0-CA83-47CA-96DB-560BA4E2AFB3Q38873507-A7AA6451-99FD-4D08-97B9-7F34A7E6B3D7Q39739201-5B1B2394-48EA-4755-8FAF-F360B33B71A5Q41605967-5305F690-0A1B-42B9-A33F-74F34E1E2DB6Q47271759-6410CD46-C310-48CF-A2AD-1E55532C11C1Q48487351-3FE630C9-F678-47F1-8E4A-49A0FAEBD9E3
P2860
Serum cystatin C and the risk of Alzheimer disease in elderly men
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on September 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Serum cystatin C and the risk of Alzheimer disease in elderly men
@en
Serum cystatin C and the risk of Alzheimer disease in elderly men.
@nl
type
label
Serum cystatin C and the risk of Alzheimer disease in elderly men
@en
Serum cystatin C and the risk of Alzheimer disease in elderly men.
@nl
prefLabel
Serum cystatin C and the risk of Alzheimer disease in elderly men
@en
Serum cystatin C and the risk of Alzheimer disease in elderly men.
@nl
P2093
P2860
P50
P1433
P1476
Serum cystatin C and the risk of Alzheimer disease in elderly men
@en
P2093
B Zethelius
E Rönnemaa
J Sundelöf
L Kilander
L Lannfelt
M C Irizarry
M Degerman-Gunnarsson
P2860
P304
P356
10.1212/01.WNL.0000326894.40353.93
P407
P577
2008-09-01T00:00:00Z